Navigation Links
Applying brakes to symptoms of Alzheimer's with a tiny implant

In what holds promise for a large number of Alzheimer's patients, a breakthrough has arrived in the form of an inch long contraption designed to be implanted under// the skin on the abdomen. Indeed a promising treatment option, this implant contains a medicine that is slowly pumped into the patient's blood stream. According to the results of the clinical trails of this implant, the medicine is capable of retarding the progress of the disease for up to a year.

Each contraption is designed to last up till 6 months, all the while letting out a consistent dosage to control the symptoms of Alzheimer's. Once the contents of device are completely used up, it simply blends into the blood stream, without causing any harm.

The greatest advantage in this device is that apart from obliterating the need for the daily or weekly drug injections, it will effectively offset the ups and downs in the symptoms, which normally occur with medicines that are swallowed or injected. The overriding benefit is the fact that patients in the throes of memory loss need not be concerned about ensuring regular intake of drugs.

Leuprolide acetate, the medicine which has been in use for over two decades to treat prostate cancer is now being used inside the implant and research has shown that is capable of retarding the progress of Alzheimer's.

Susanne Sorenson, head of research at the Alzheimer's society said 'Tests on mice have shown it is effective in reducing levels of a chemical strongly associated with Alzheimer's, and first tests on humans have indicated it could help slow the progression of the disease. But it's too early to tell if it will stop the disease developing.'


Page: 1

Related medicine news :

1. Dialing On Cell Phones Or Applying Make-Up Increase Crash Risk
2. Cell transplants used to fend off Parkinsons symptoms
3. Occupational exposurer aises respiratory symptoms
4. New drug to multiple sclerosis symptoms
5. Warding off symptoms of premenstrual syndrome by combination therapy
6. Women who had stopped HRT get back their symptoms
7. Beat menopausal symptoms with low-dose estrogen
8. Dark chocolate can help ease symptoms of diarrhea
9. Synthetic protein found to relieve arthritis symptoms in animal model
10. Reversibility of symptoms of depression using CPAP in patients with obstructive sleep apnea
11. Physical activity may help relieve gastrointestinal symptoms in obese people
Post Your Comments:

(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: